Clinical efficacy and mechanism of transcutaneous neuromodulation on ineffective esophageal motility in patients with gastroesophageal reflux disease

Yimin Ma,Rencheng Cai,Zhengqing Liu,Xiaoping Zou,Zhenguo Qiao
DOI: https://doi.org/10.1111/nmo.14464
2022-10-20
Abstract:Effects of acute Transcutaneous Neuromodulation (TN) ST36 on autonomic nervous function: After acute TN ST36 treatment, vagus nerve activity of enrolled patients (Ineffective esophageal motility in Patients with Gastroesophageal Reflux Disease) increased significantly, sympathetic nerve activity decreased significantly, and sympathetic vagus ratio also decreased significantly. Background Esophageal motility disorder is one of the pathogenesis of gastroesophageal reflux disease (GERD). The clinical and functional relationship between the ineffective esophageal motility (IEM) and GERD have been found. PPI is a widely used drug of this diaease, but some patients have poor efficacy. The purpose of this study was to investigate the efficacy and possible mechanism of Transcutaneous Neuromodulation in these patients. Methods Fifty‐six patients with GERD with IEM were enrolled and randomly divided into two groups, one group was TN ST‐36 group, the other group was sham TN group. The GERD questionnaire (GerdQ), quality of life score, MOS item short from health survey (SF‐36), Hospital Anxiety and Depression Scale (HADS) were used to assess the severity of symptoms. High‐resolution esophageal manometry (HRM) test was performed to assess low esophageal sphincter (LES) pressure and distal contractile integral (DCI). The heart rate variability (HRV) test was performed to assess autonomic nervous function. Key Results Compared with sham TN, chronic TN treatment decreased the GERD‐Q score (p
gastroenterology & hepatology,neurosciences,clinical neurology
What problem does this paper attempt to address?